Zai Lab

Zai Lab Retained Earnings

The Retained Earnings of Zai Lab (ZLAB) as of Nov 22, 2026 is -2.63 B USD. In the previous year, Retained Earnings was -2.45 B USD — a change of 7.16% (lower).

Retained Earnings

-2.63 BUSD

YoY

7.16%

Last updated:

Retained Earnings of Zai Lab is 2025 -2.63 B USD. Retained Earnings of Zai Lab was 2024 -2.45 B USD. It decreases by 7.16% lower compared to the previous year.

The Zai Lab Retained Earnings history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Retained Earnings
Date
Retained Earnings
Jan 1, 2018
-249.63 M USD
Jan 1, 2019
-444.70 M USD
Jan 1, 2020
-713.60 M USD
Jan 1, 2021
-1.42 B USD
Jan 1, 2022
-1.86 B USD
Jan 1, 2023
-2.20 B USD
Jan 1, 2024
-2.45 B USD
Jan 1, 2025
-2.63 B USD
The Zai Lab Retained Earnings history
YEARRetained EarningsYoY
-2.63 BUSD+7.16%
-2.45 BUSD+11.71%
-2.20 BUSD+17.98%
-1.86 BUSD+31.26%
-1.42 BUSD+98.72%
-713.60 MUSD+60.47%
-444.70 MUSD+78.15%
-249.63 MUSD+125.80%
-110.55 MUSD+83.74%
-60.17 MUSD+165.58%
-22.66 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zai Lab Stock analysis

What does Zai Lab do? Zai Lab Ltd, based in Pudong, China, is a biopharmaceutical company operating in the Health Care sector. It develops and commercializes innovative treatments for oncology, immunology, neuroscience, and infectious diseases. The company offers products such as Zejula for ovarian cancer, VYVGART for myasthenia gravis, NUZYRA for bacterial infections, Optune for brain tumors, Qinlock for gastrointestinal tumors, Xacduro for bacterial pneumonia, and Augtyro for lung cancer. Zai Lab collaborates with leading pharmaceutical firms including Pfizer and Amgen. Zai Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zai Lab stock

Retained Earnings of Zai Lab is -2.63 B USD in 2025.

Retained Earnings of Zai Lab changed from -2.45 B USD to -2.63 B USD, representing a 7.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Retained Earnings Zai Lab since 2006 – with annual values, charts, and detailed analysis.

Retained earnings are the cumulative net income kept in the business rather than paid out as dividends. They fund future growth and operations.

Retained Earnings's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Retained Earnings's Zai Lab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Zai Lab

All Key Metrics — Zai Lab